BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 12058212)

  • 1. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors.
    Lee JW; Han JK; Kim TK; Choi BI; Park SH; Ko YH; Yoon CJ; Yeon KM
    Cardiovasc Intervent Radiol; 2002; 25(3):176-9. PubMed ID: 12058212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of percutaneous transhepatic biliary drainage in patients with obstructive jaundice caused by local recurrence of gastric cancer.
    Makino T; Fujitani K; Tsujinaka T; Hirao M; Kashiwazaki M; Nakamori S; Ikenaga M; Mishima H; Masuda N; Sawamura T
    Hepatogastroenterology; 2008; 55(81):54-7. PubMed ID: 18507078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Obstructive icterus in patients with hepatic tumor. Result of non-surgical biliary drainage].
    Hagege H; de Montigny S; Ink O; Fritsch J; Choury AD; Liguory C; Etienne JP
    Gastroenterol Clin Biol; 1990; 14(2):115-9. PubMed ID: 2328878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are endoscopic or percutaneous biliary drainage effective for obstructive jaundice caused by hepatocellular carcinoma?
    Cho HC; Lee JK; Lee KH; Lee KT; Paik S; Choo SW; Do YS; Choo IW
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):224-31. PubMed ID: 21228705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma with tumor thrombi in the bile duct.
    Wang HJ; Kim JH; Kim JH; Kim WH; Kim MW
    Hepatogastroenterology; 1999; 46(28):2495-9. PubMed ID: 10522026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous transhepatic biliary drainage in the management of obstructive jaundice.
    Baijal SS; Dhiman RK; Gupta S; Sharma BC; Roy S; Agarwal DK; Choudhuri G; Saraswat VA; Naik SR
    Trop Gastroenterol; 1997; 18(4):167-71. PubMed ID: 9612100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of percutaneous cholangiography and percutaneous biliary drainage in obstructive jaundice.
    Lukes P; Ceder S; Wihed A; Falk A; Gamklou R
    Eur J Radiol; 1985 Nov; 5(4):267-70. PubMed ID: 4085489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting.
    Brountzos EN; Ptochis N; Panagiotou I; Malagari K; Tzavara C; Kelekis D
    Cardiovasc Intervent Radiol; 2007; 30(1):66-73. PubMed ID: 17031733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and clinical studies on liver regeneration following transcatheter portal embolization.
    Ishikawa M; Yogita S; Iuchi M; Yagi K; Chikaishi H; Fukuda Y; Miyake H; Harada M; Tashiro S
    Hepatogastroenterology; 2000; 47(31):226-33. PubMed ID: 10690613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of percutaneous transhepatic biliary drainage in the correction of the metabolic capacity of the jaundiced liver by hippurate-synthesizing test.
    Kamiyama Y; Tokunaga Y; Aoyama H; Ukikusa M; Ozawa K
    Surg Gynecol Obstet; 1993 Jul; 177(1):72-6. PubMed ID: 8322155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of biliary drainage for obstructive jaundice caused by colorectal and gastric cancers.
    Kasuga A; Ishii H; Ozaka M; Matsusaka S; Chin K; Mizunuma N; Yukisawa S; Matsueda K; Furuse J
    Jpn J Clin Oncol; 2012 Dec; 42(12):1161-7. PubMed ID: 23072841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventional therapy of malignant obstructive jaundice.
    Feng GH; Cai Y; Jia Z; Yang DQ; Chen H; Jin HC; Yu QH; Zhu W; Wang CX
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):300-2. PubMed ID: 14599989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma presenting with obstructive jaundice.
    Lai EC; Lau WY
    ANZ J Surg; 2006 Jul; 76(7):631-6. PubMed ID: 16813631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstructive jaundice caused by tumor emboli from hepatocellular carcinoma.
    Hu J; Pi Z; Yu MY; Li Y; Xiong S
    Am Surg; 1999 May; 65(5):406-10. PubMed ID: 10231205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstructive jaundice secondary to ruptured hepatocellular carcinoma into the common bile duct. Surgical experiences of 20 cases.
    Chen MF; Jan YY; Jeng LB; Hwang TL; Wang CS; Chen SC
    Cancer; 1994 Mar; 73(5):1335-40. PubMed ID: 8111698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors after percutaneous transhepatic biliary drainage].
    Castoldi MC; Pisani P; Ideo G; Bellomi M; Cozzi G; Severini A
    Radiol Med; 1991 May; 81(5):695-8. PubMed ID: 2057599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obstructive jaundice caused by hepatocellular carcinoma].
    Nardello O; Farina GP; Cagetti M
    Ann Ital Chir; 2005; 76(6):535-41. PubMed ID: 16821515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of surgical risk in preoperative biliary drainage patients by blood chemistry laboratory data--with special reference to rate of reduction of serum bilirubin levels.
    Nakayama T; Tamae T; Kinoshita H; Okuda K; Imayama Y; Saitoh N; Shibata J; Aoki E; Hasuda A; Saitsu H
    Hepatogastroenterology; 1995; 42(4):338-42. PubMed ID: 8586364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epirubicin in the treatment of malignant obstructive jaundice].
    Chen Y; Yan ZP; Wang JH; Wang XL; Cheng JM; Gong GQ; Liu QX; Qian S; Liu R; Luo JJ
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):397-9. PubMed ID: 17045011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential changes of bile contents in patients with obstructive jaundice from different etiologies.
    Chen CY; Shiesh SC; Su WC; Chang KK; Lin XZ
    Hepatogastroenterology; 1996; 43(10):796-9. PubMed ID: 8884292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.